- Home
- BKYI vs BFRI Comparison
BKYI vs BFRI Comparison
Compare BKYI & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BKYI | BFRI |
|---|---|---|
| Founded | 1993 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3M | 8.4M |
| IPO Year | 1997 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BKYI | BFRI |
|---|---|---|
| Price | $0.58 | $0.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | ★ 278.2K | 89.4K |
| Earning Date | 11-14-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,316,050.00 | ★ $37,164,000.00 |
| Revenue This Year | $7.45 | $9.70 |
| Revenue Next Year | $23.29 | $10.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.11 |
| 52 Week Low | $0.53 | $0.54 |
| 52 Week High | $3.68 | $1.87 |
Technical Indicators
Market Signals| Indicator | BKYI | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 36.72 | 37.13 |
| Support Level | $0.53 | $0.70 |
| Resistance Level | $0.63 | $0.75 |
| Average True Range (ATR) | 0.04 | 0.05 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 21.48 | 15.48 |
Price Performance
Historical ComparisonAbout BKYI BIO-key International Inc.
BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.